why choose us

First received: June 19, 2025

Clinical Trial: A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Head and Neck Squamous Cell Carcinoma
Low-dose Radiotherapy
Immunotherapy
Targeted Th

Study Type: INTERVENTIONAL


Official Title: A Prospective Randomized Controlled Trial Comparing Low-Dose Radiotherapy Combined With Targeted Therapy and Immunotherapy Versus Targeted Therapy and Immunotherapy Alone as Neoadjuvant Therapy in Pat

Brief Summary: This study aimed to compare the efficacy of neoadjuvant low-dose radiotherapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone in patients with resectable head and neck squamous cell carcinoma.

Read more